RecruitingNCT07433777

Reference Intervals With Indirect Methods in Italy


Sponsor

Centro di Riferimento Oncologico - Aviano

Enrollment

1,000,000 participants

Start Date

Oct 8, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Reference intervals are an essential tool for the clinical interpretation of laboratory test results. Traditionally, these interval are determined using samples from healthy individuals, a process that is resource-intensive, time-consuming, and require the active recruitment of healthy volunteers. In recent years, due to the increasing availability of electronic health record (EHR) databases and the growing number of laboratory tests, it is possible to determine the reference intervals indirectly. This approach relies on the analysis of routine data acquired in clinical laboratories, eliminating the need for active recruiting healthy subjects and significantly reducing costs. Moreover, the method has the potential to eliminate the selection bias of an ultra-healthy population typical of the direct methods. The indirect methods for determining reference intervals have evolved from simple strategies of isolating the healthy population using sample metadata, to sophisticated statistical models that effectively distinguish normal from pathological distributions. One of the advanced techniques, RefineR, has reached an excellent combination of accuracy, robustness, and computational efficiency, outperforming previous methods. It has been implemented as an open-source R package, facilitating its application in real-world settings. In recognition of these advantages, the IFCC (International Federation of Clinical Chemistry and Laboratory Medicine), through its Committee on Reference Intervals and Decision Limits (C-RIDL), has promoted the adoption of indirect methods for determining reference intervals, highlighting the advantages of this strategy, including greater speed, lower costs, and the absence of a need to recruit healthy donors. Furthermore, a recent study has highlighted age-related physiological variations in hemoglobin levels in elderly population. This underscores the need for defining age-specific reference intervals which are currently absent from most laboratory reports, potentially impacting diagnostic accuracy.


Eligibility

Min Age: 0 YearsMax Age: 100 Years

Inclusion Criteria1

  • no one

Exclusion Criteria1

  • no one

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(24)

ASL Bari, Ospedale della Murgia, Altamura

Altamura, Altamura, Italy

Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona

Ancona, Ancona, Italy

Azienda USL Toscana Sud Est, Arezzo

Arezzo, Arezzo, Italy

Azienda ULSS 1 Dolomiti

Belluno, Belluno, Italy

Azienda Ospedaliero-Universitaria Careggi, Firenze

Florence, Firenze, Italy

IRCCS Istituto Clinico Humanitas, Milano

Milan, Milano, Italy

IRCCS Ospedale San Raffaele, Milano

Milan, Milano, Italy

Azienda Ospedaliero-Universitaria di Modena

Modena, Modena, Italy

Bianalisi Carate Brianza, Monza e Brianza

Monza, Monza, Italy

Azienda Ospedaliero-Universitaria Maggiore della Carità di Novara

Novara, Novara, Italy

Azienda Ospedale Università Padova

Padova, Padova, Italy

Azienda Ospedaliera Universitaria Policlinico 'Paolo Giaccone' di Palermo

Palermo, Palermo, Italy

Centro di Riferimento Oncolgico -IRCCS

Aviano, Pordenone, Italy

Azienda Sanitaria Friuli Occidentale, Ospedale di Pordenone

Pordenone, Pordenone, Italy

Azienda Ospedaliera Universitaria Senese,

Siena, Siena, Italy

Azienda Sanitaria Universitaria Giuliano Isontina

Trieste, Trieste, Italy

Azienda Sanitaria Universitaria Friuli Centrale, Ospedale di Udine

Udine, Udine, Italy

AULSS 3 Serenissima, Ospedale di Mestre

Mestre, Venezia, Italy

Azienda Ospedaliera Universitaria Integrata di Verona

Verona, Verona, Italy

AULSS 8 Berica, Ospedale S. Bortolo di Vicenza

Vicenza, Vicenza, Italy

Ospedale di Desio, ASST Brianza

Desio, Italy

ASL5 Spezzino, La Spezia

La Spezia, Italy

ASST Grande Ospedale Metropolitano Niguarda, Milano

Milan, Italy

Azienda ULSS 2 Marca Trevigiana

Treviso, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07433777